Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4465957 | 5661147 | I | 4465957-1 | 20040811 | 20040918 | 20040930 | EXP | A-CH2004-07444 | ACTELION PHARMACEUTICALS US, INC. | 75 | YR | F | N | 64.9 | KG | 20040929 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4465957 | 1005264977 | PS | TRACLEER | 1 | ORAL | SEE IMAGE | U | D | 21290 | ||
| 4465957 | 1005287220 | C | FUROSEMIDE | 1 | |||||||
| 4465957 | 1005287221 | C | CITALOPRAM | 1 | |||||||
| 4465957 | 1005287223 | C | WARFARIN (WARFARIN) | 2 | |||||||
| 4465957 | 1005287224 | C | THYROXIN (LEVOTHYROXINE SODIUM) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4465957 | 1005264977 | PULMONARY HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4465957 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4465957 | ALANINE AMINOTRANSFERASE INCREASED |
| 4465957 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 4465957 | BLOOD BILIRUBIN INCREASED |
| 4465957 | LIVER FUNCTION TEST ABNORMAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4465957 | FGN |
| 4465957 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4465957 | 1005264977 | 20030213 | 20030312 | ||
| 4465957 | 1005264977 | 20040906 | |||
| 4465957 | 1005264977 | 20030313 | |||
| 4465957 | 1005264977 | 20040907 |